DK1853244T3 - Metode til behandling af præmatur retinopati og relaterede retinopatiske sygdomme - Google Patents

Metode til behandling af præmatur retinopati og relaterede retinopatiske sygdomme

Info

Publication number
DK1853244T3
DK1853244T3 DK06736134.5T DK06736134T DK1853244T3 DK 1853244 T3 DK1853244 T3 DK 1853244T3 DK 06736134 T DK06736134 T DK 06736134T DK 1853244 T3 DK1853244 T3 DK 1853244T3
Authority
DK
Denmark
Prior art keywords
cells
retina
retinopatic
diseases
pharmaceutical composition
Prior art date
Application number
DK06736134.5T
Other languages
English (en)
Inventor
Martin Friedlander
Eyal Banin
Edith Aguilar
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of DK1853244T3 publication Critical patent/DK1853244T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06736134.5T 2005-02-24 2006-02-24 Metode til behandling af præmatur retinopati og relaterede retinopatiske sygdomme DK1853244T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65612205P 2005-02-24 2005-02-24
PCT/US2006/006744 WO2006091895A2 (en) 2005-02-24 2006-02-24 Method for the treatment of retinopathy of prematurity and related retinopathic diseases

Publications (1)

Publication Number Publication Date
DK1853244T3 true DK1853244T3 (da) 2013-09-30

Family

ID=36928090

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07021593.4T DK1935976T3 (da) 2005-02-24 2006-02-24 Transficerede myeloid-lignende celler til behandling af retinopati ved for tidlig fødsel og dermed relaterede sygdomme
DK06736134.5T DK1853244T3 (da) 2005-02-24 2006-02-24 Metode til behandling af præmatur retinopati og relaterede retinopatiske sygdomme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07021593.4T DK1935976T3 (da) 2005-02-24 2006-02-24 Transficerede myeloid-lignende celler til behandling af retinopati ved for tidlig fødsel og dermed relaterede sygdomme

Country Status (13)

Country Link
US (1) US20080317721A1 (da)
EP (2) EP1853244B1 (da)
JP (1) JP5173442B2 (da)
CN (1) CN101356268A (da)
AT (1) ATE545697T1 (da)
AU (1) AU2006216473B2 (da)
CA (1) CA2599172A1 (da)
DK (2) DK1935976T3 (da)
ES (2) ES2427966T3 (da)
PL (1) PL1935976T3 (da)
PT (1) PT1935976E (da)
RU (1) RU2403906C2 (da)
WO (1) WO2006091895A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7931891B2 (en) * 2005-02-24 2011-04-26 The Scripps Research Institute Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
KR101244202B1 (ko) * 2005-02-24 2013-03-18 더 스크립스 리서치 인스티튜트 허혈성 망막 조직의 혈관재형성 및 이의 스크리닝 방법
DK2046349T3 (da) * 2006-07-12 2015-12-21 Mesoblast Inc Behandling af excessiv neovaskularisering
EP2279247B1 (en) * 2008-04-22 2019-01-02 Regenerative Research Foundation Retinal pigment epithelial stem cells
US20130156773A1 (en) * 2010-06-18 2013-06-20 Women And Infants Hospital Of Rhode Island Lung regeneration using cord blood-derived hematopoietic stem cells
RU2445944C1 (ru) * 2010-10-14 2012-03-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных
RU2445943C1 (ru) * 2010-10-14 2012-03-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных
RU2445945C1 (ru) * 2010-10-14 2012-03-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных
RU2445946C1 (ru) * 2010-10-14 2012-03-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных
RU2464958C2 (ru) * 2010-11-26 2012-10-27 Государственное учреждение здравоохранения Свердловской области детская клиническая больница восстановительного лечения "Научно-практический центр "Бонум" Способ хирургического лечения рубцовых стадий ретинопатии недоношенных
EP2554662A1 (en) 2011-08-05 2013-02-06 M Maria Pia Cosma Methods of treatment of retinal degeneration diseases
US20150079047A1 (en) * 2012-04-16 2015-03-19 The Regents Of The University Of California Ocular therapeutics using embryonic stem cell microvesicles
RU2496871C1 (ru) * 2012-08-09 2013-10-27 Сергей Владимирович Осутин Способ выделения стволовых клеток из костного мозга для внутрисосудистого введения
CN107038704B (zh) * 2017-05-04 2020-11-06 季鑫 视网膜图像渗出区域分割方法、装置和计算设备
RU2729031C1 (ru) * 2020-03-13 2020-08-03 федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ хирургического лечения пролиферативной диабетической ретинопатии, осложненной гемофтальмом и тракционной отслойкой сетчатки
US20230181686A1 (en) * 2020-05-27 2023-06-15 Baylor College Of Medicine Compositions and methods for treating neovascularization and ischemic retinopathies by targeting angiogenesis and cholesterol transport

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
BR0312920A (pt) * 2002-07-25 2007-07-10 Scripps Research Inst células tronco hematopoéticas e métodos de tratamento de doenças oculares neovasculares com as mesmas
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
WO2006031467A2 (en) * 2002-07-25 2006-03-23 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
US20070231306A1 (en) * 2005-02-24 2007-10-04 The Scripps Research Institute Isolated myeloid-like cell populations and methods of treatment therewith

Also Published As

Publication number Publication date
EP1853244A2 (en) 2007-11-14
US20080317721A1 (en) 2008-12-25
EP1935976A1 (en) 2008-06-25
JP5173442B2 (ja) 2013-04-03
EP1853244B1 (en) 2013-07-17
AU2006216473B2 (en) 2012-07-26
AU2006216473A1 (en) 2006-08-31
ES2382357T3 (es) 2012-06-07
ATE545697T1 (de) 2012-03-15
JP2008536804A (ja) 2008-09-11
CA2599172A1 (en) 2006-08-31
RU2007135220A (ru) 2009-03-27
ES2427966T3 (es) 2013-11-05
PT1935976E (pt) 2012-05-15
DK1935976T3 (da) 2012-04-10
PL1935976T3 (pl) 2012-07-31
RU2403906C2 (ru) 2010-11-20
WO2006091895A2 (en) 2006-08-31
WO2006091895A3 (en) 2008-09-12
CN101356268A (zh) 2009-01-28
EP1935976B1 (en) 2012-02-15
EP1853244A4 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
DK1853244T3 (da) Metode til behandling af præmatur retinopati og relaterede retinopatiske sygdomme
Gkotsi et al. Recharging mitochondrial batteries in old eyes. Near infra-red increases ATP
Jiang et al. Nrf2/ARE is a key pathway for curcumin-mediated protection of TMJ chondrocytes from oxidative stress and inflammation
Xu et al. Nrf2 activation in astrocytes contributes to spinal cord ischemic tolerance induced by hyperbaric oxygen preconditioning
CY1124074T1 (el) Φαρμακευτικες συνθεσεις για θεραπεια υποκαταστασης γλυκοκορτικοειδων
Kalonia et al. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-ϒ (PPARϒ) in Huntington's disease
Kumar et al. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats
CR8380A (es) Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos
EA201071059A1 (ru) Способы и композиции для лечения воспаления и связанных с воспалением патологических состояний
EA201200489A1 (ru) Фармацевтическая композиция, включающая новый холиновый сокристалл эпалрестата
RS52921B (en) TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
EA020849B1 (ru) Применение 1,3-дифенилпроп-2-ен-1-оновых производных для лечения заболеваний печени
WO2008103993A3 (en) Compositions and methods for treating glycogen storage diseases
NO20073699L (no) Stabile protaglandin-inneholdende preparater
NO20063483L (no) Therapeutic combinations
NZ578928A (en) Methods to increase mobility of hematopoietic stem cells by use of a lipopeptide compound and treatment of associated diseases
Naqvi et al. Curcumin lessens unpredictable chronic mild stress-induced depression and memory deficits by modulating oxidative stress and cholinergic activity
ATE516366T1 (de) Regulierte aptamer-therapeutika
Mishra et al. Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington’s disease
EA200701017A1 (ru) Применение рибозы-цистеина для лечения гипоксии
Takeuchi-Igarashi et al. Matrix remodeling response of human periodontal tissue cells toward fibrosis upon nicotine exposure
ES2878063T3 (es) Derivados de la alfa-aminoamida para el tratamiento de trastornos psiquiátricos
Ottana et al. Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures
Roy Chowdhury et al. Ocular hypotensive effects of the ATP-sensitive potassium channel opener cromakalim in human and murine experimental model systems
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen